Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum

Detalhes bibliográficos
Autor(a) principal: Cordeiro, Rossana de Aguiar
Data de Publicação: 2014
Outros Autores: Marques, Francisca Jakelyne de Farias, Cordeiro, Rebecca de Aguiar, Silva, Marcos Reinaldo da, Malaquias, Angela Donato Maia, Melo, Charlline Vládia Silva de, Mafezoli, Jair, Oliveira, Maria da Conceição Ferreira de, Brilhante, Raimunda Sâmia Nogueira, Rocha, Marcos Fábio Gadelha, Bandeira, Tereza de Jesus Pinheiro Gomes, Sidrim, José Júlio Costa
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da Universidade Federal do Ceará (UFC)
Texto Completo: http://www.repositorio.ufc.br/handle/riufc/9453
Resumo: Histoplasmosis is a severe infection that affects millions of patients worldwide and is endemic in the Americas. Amphotericin B (AMB) and itraconazole are highly effective for the treatment of severe and milder forms of the disease, but AMB is toxic, and the bioavailability of itraconazole is erratic. Therefore, it is important to investigate new classes of drugs for histoplasmosis treatment. In this study, a series of nine isoniazid hydrazone derivatives were synthesized and evaluated for their antifungal activities in vitro against the dimorphic fungus Histoplasma capsulatum var. capsulatum. The drugs were tested by microdilution in accordance with CLSI guidelines. The compound N=-(1-phenylethylidene)isonicotinohydrazide had the lowest MIC range of all the compounds for the yeast and filamentous forms of H. capsulatum. The in vitro synergy of this compound with AMB against the planktonic and biofilm forms of H. capsulatum cells was assessed by the checkerboard method. The effects of this hydrazone on cellular ergosterol content and membrane integrity were also investigated. The study showed that the compound alone is able to reduce the ergosterol content of planktonic cells and can alter the membrane permeability of the fungus. Furthermore, the compound alone or in combination with AMB showed inhibitory effects against mature biofilms of H. capsulatum. N=-(1-Phenylethylidene)isonicotinohydrazide alone or combined with AMB might be of interest in the management of histoplasmosis.
id UFC-7_4a900b25f6518c4bc3b140263bea0b39
oai_identifier_str oai:repositorio.ufc.br:riufc/9453
network_acronym_str UFC-7
network_name_str Repositório Institucional da Universidade Federal do Ceará (UFC)
repository_id_str
spelling Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatumHistoplasmaAnfotericina BHistoplasmosis is a severe infection that affects millions of patients worldwide and is endemic in the Americas. Amphotericin B (AMB) and itraconazole are highly effective for the treatment of severe and milder forms of the disease, but AMB is toxic, and the bioavailability of itraconazole is erratic. Therefore, it is important to investigate new classes of drugs for histoplasmosis treatment. In this study, a series of nine isoniazid hydrazone derivatives were synthesized and evaluated for their antifungal activities in vitro against the dimorphic fungus Histoplasma capsulatum var. capsulatum. The drugs were tested by microdilution in accordance with CLSI guidelines. The compound N=-(1-phenylethylidene)isonicotinohydrazide had the lowest MIC range of all the compounds for the yeast and filamentous forms of H. capsulatum. The in vitro synergy of this compound with AMB against the planktonic and biofilm forms of H. capsulatum cells was assessed by the checkerboard method. The effects of this hydrazone on cellular ergosterol content and membrane integrity were also investigated. The study showed that the compound alone is able to reduce the ergosterol content of planktonic cells and can alter the membrane permeability of the fungus. Furthermore, the compound alone or in combination with AMB showed inhibitory effects against mature biofilms of H. capsulatum. N=-(1-Phenylethylidene)isonicotinohydrazide alone or combined with AMB might be of interest in the management of histoplasmosis.Antimicrobial Agents and Chemotherapy2014-10-15T11:55:10Z2014-10-15T11:55:10Z2014-05info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfCORDEIRO, R. A. et al. Synthesis and antifungal activity in vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum. Antimicrobial Agents and Chemotherapy, Bethesda, v. 58, n. 5, p. 2504-2511, maio, 2014.0066-4804 Impresso1098-6596 On linehttp://www.repositorio.ufc.br/handle/riufc/9453Cordeiro, Rossana de AguiarMarques, Francisca Jakelyne de FariasCordeiro, Rebecca de AguiarSilva, Marcos Reinaldo daMalaquias, Angela Donato MaiaMelo, Charlline Vládia Silva deMafezoli, JairOliveira, Maria da Conceição Ferreira deBrilhante, Raimunda Sâmia NogueiraRocha, Marcos Fábio GadelhaBandeira, Tereza de Jesus Pinheiro GomesSidrim, José Júlio Costaengreponame:Repositório Institucional da Universidade Federal do Ceará (UFC)instname:Universidade Federal do Ceará (UFC)instacron:UFCinfo:eu-repo/semantics/openAccess2021-03-30T13:25:30Zoai:repositorio.ufc.br:riufc/9453Repositório InstitucionalPUBhttp://www.repositorio.ufc.br/ri-oai/requestbu@ufc.br || repositorio@ufc.bropendoar:2024-09-11T19:00:51.342477Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC)false
dc.title.none.fl_str_mv Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum
title Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum
spellingShingle Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum
Cordeiro, Rossana de Aguiar
Histoplasma
Anfotericina B
title_short Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum
title_full Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum
title_fullStr Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum
title_full_unstemmed Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum
title_sort Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum
author Cordeiro, Rossana de Aguiar
author_facet Cordeiro, Rossana de Aguiar
Marques, Francisca Jakelyne de Farias
Cordeiro, Rebecca de Aguiar
Silva, Marcos Reinaldo da
Malaquias, Angela Donato Maia
Melo, Charlline Vládia Silva de
Mafezoli, Jair
Oliveira, Maria da Conceição Ferreira de
Brilhante, Raimunda Sâmia Nogueira
Rocha, Marcos Fábio Gadelha
Bandeira, Tereza de Jesus Pinheiro Gomes
Sidrim, José Júlio Costa
author_role author
author2 Marques, Francisca Jakelyne de Farias
Cordeiro, Rebecca de Aguiar
Silva, Marcos Reinaldo da
Malaquias, Angela Donato Maia
Melo, Charlline Vládia Silva de
Mafezoli, Jair
Oliveira, Maria da Conceição Ferreira de
Brilhante, Raimunda Sâmia Nogueira
Rocha, Marcos Fábio Gadelha
Bandeira, Tereza de Jesus Pinheiro Gomes
Sidrim, José Júlio Costa
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Cordeiro, Rossana de Aguiar
Marques, Francisca Jakelyne de Farias
Cordeiro, Rebecca de Aguiar
Silva, Marcos Reinaldo da
Malaquias, Angela Donato Maia
Melo, Charlline Vládia Silva de
Mafezoli, Jair
Oliveira, Maria da Conceição Ferreira de
Brilhante, Raimunda Sâmia Nogueira
Rocha, Marcos Fábio Gadelha
Bandeira, Tereza de Jesus Pinheiro Gomes
Sidrim, José Júlio Costa
dc.subject.por.fl_str_mv Histoplasma
Anfotericina B
topic Histoplasma
Anfotericina B
description Histoplasmosis is a severe infection that affects millions of patients worldwide and is endemic in the Americas. Amphotericin B (AMB) and itraconazole are highly effective for the treatment of severe and milder forms of the disease, but AMB is toxic, and the bioavailability of itraconazole is erratic. Therefore, it is important to investigate new classes of drugs for histoplasmosis treatment. In this study, a series of nine isoniazid hydrazone derivatives were synthesized and evaluated for their antifungal activities in vitro against the dimorphic fungus Histoplasma capsulatum var. capsulatum. The drugs were tested by microdilution in accordance with CLSI guidelines. The compound N=-(1-phenylethylidene)isonicotinohydrazide had the lowest MIC range of all the compounds for the yeast and filamentous forms of H. capsulatum. The in vitro synergy of this compound with AMB against the planktonic and biofilm forms of H. capsulatum cells was assessed by the checkerboard method. The effects of this hydrazone on cellular ergosterol content and membrane integrity were also investigated. The study showed that the compound alone is able to reduce the ergosterol content of planktonic cells and can alter the membrane permeability of the fungus. Furthermore, the compound alone or in combination with AMB showed inhibitory effects against mature biofilms of H. capsulatum. N=-(1-Phenylethylidene)isonicotinohydrazide alone or combined with AMB might be of interest in the management of histoplasmosis.
publishDate 2014
dc.date.none.fl_str_mv 2014-10-15T11:55:10Z
2014-10-15T11:55:10Z
2014-05
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv CORDEIRO, R. A. et al. Synthesis and antifungal activity in vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum. Antimicrobial Agents and Chemotherapy, Bethesda, v. 58, n. 5, p. 2504-2511, maio, 2014.
0066-4804 Impresso
1098-6596 On line
http://www.repositorio.ufc.br/handle/riufc/9453
identifier_str_mv CORDEIRO, R. A. et al. Synthesis and antifungal activity in vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum. Antimicrobial Agents and Chemotherapy, Bethesda, v. 58, n. 5, p. 2504-2511, maio, 2014.
0066-4804 Impresso
1098-6596 On line
url http://www.repositorio.ufc.br/handle/riufc/9453
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Antimicrobial Agents and Chemotherapy
publisher.none.fl_str_mv Antimicrobial Agents and Chemotherapy
dc.source.none.fl_str_mv reponame:Repositório Institucional da Universidade Federal do Ceará (UFC)
instname:Universidade Federal do Ceará (UFC)
instacron:UFC
instname_str Universidade Federal do Ceará (UFC)
instacron_str UFC
institution UFC
reponame_str Repositório Institucional da Universidade Federal do Ceará (UFC)
collection Repositório Institucional da Universidade Federal do Ceará (UFC)
repository.name.fl_str_mv Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC)
repository.mail.fl_str_mv bu@ufc.br || repositorio@ufc.br
_version_ 1813029033755017216